Vaccine Trials, Pediatric Clinical and Translational Research Unit

Vaccine Trials Unit Mission:

Addressing health inequities through safe and effective vaccine development/trials with a focus on emerging infections, HIV, and other vaccine preventable conditions.

Pediatric Clinical & Translational Research Unit Mission:

Leading innovative clinical and translational research to improve the health and well-being of all children, with emphasis on minority and medically underserved children in Georgia, US, and worldwide.

MSM COVID 19 Vaccine Trial Interest Survey

Please fill out the survey if you are interested and be a part of the changing face of research in this diverse community.

Take the Survey

MSM COVID 19 Vaccine Trial Interest Survey

Please fill out the survey if you are interested and be a part of the changing face of research in this diverse community.

Take the Survey

HUMMINGBIRD Pediatric COVID-19 Vaccine Study

Morehouse School of Medicine is participating in a new clinical trial called the HUMMINGBIRD study, a Phase 2/3 study to evaluate the safety and immunogenicity of an investigational vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in pediatric participants.

Learn More

PEARL

This study will evaluate the safety and immune response of a new candidate RSV vaccine in infants and toddlers. A Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL).

Learn More